Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masahide Yamamoto

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Anticancer Research|May 7, 2017
Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution StudyMasahide Yamamoto, Ken Watanabe, Tetsuya Fukuda, et al.
Biochemical and Biophysical Research Communications|August 9, 2005
Calmodulin physically interacts with the erythropoietin receptor and enhances Jak2-mediated signalingKazuhiko Kakihana, Masahide Yamamoto, Mitsuko Iiyama, et al.
Internal Medicine (Tokyo, Japan)|May 7, 2016
Postoperative Atypical Hemolytic Uremic Syndrome Treated Successfully with EculizumabShunichiro Yasuda, Masahide Yamamoto, Tetsuya Fukuda, et al.
Cancer Genetics and Cytogenetics|February 22, 2005
Clonal evolution with inv(11)(p15q22) and NUP98/DDX10 fusion gene in imatinib-resistant chronic myelogenous leukemiaMasahide Yamamoto, Kazuhiko Kakihana, Tetsuya Kurosu, et al.
Biochemical and Biophysical Research Communications|June 15, 2004
The two major imatinib resistance mutations E255K and T315I enhance the activity of BCR/ABL fusion kinaseMasahide Yamamoto, Tetsuya Kurosu, Kazuhiko Kakihana, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|December 24, 2002
Endoscopic versus conventional open thyroid lobectomy for benign thyroid nodules: a prospective studyMasahide Yamamoto, Akira Sasaki, Hiroshi Asahi, et al.
Molecular and Clinical Oncology|March 24, 2015
Evaluation of the efficacy of maintenance therapy for low-to-intermediate-risk acute promyelocytic leukemia in molecular remission: A retrospective single-institution studyMasahide Yamamoto, Keigo Okada, Hiroki Akiyama, et al.
Anticancer Research|September 15, 2019
Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management StrategyMasahide Yamamoto, Keisuke Tanaka, Yoshihiro Umezawa, et al.
Cureus|October 18, 2024
Comparative Study of Metabolic Tumor Volume in Multiple Myeloma and Related Plasma Cell Dyscrasias: 11C-Acetate PET vs. 18F-FDG PETMomo Wakui, Junichi Tsuchiya, Chikara Kase, et al.
In Vivo (Athens, Greece)|September 1, 2019
Methotrexate-associated Classical Hodgkin Lymphoma Shows Distinct Clinicopathological Features but Comparable Clinical Outcomes With Sporadic CasesKota Yoshifuji, Yoshihiro Umezawa, Ayako Ichikawa, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Anticancer Research|May 7, 2017
Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution StudyMasahide Yamamoto, Ken Watanabe, Tetsuya Fukuda, et al.
Biochemical and Biophysical Research Communications|August 9, 2005
Calmodulin physically interacts with the erythropoietin receptor and enhances Jak2-mediated signalingKazuhiko Kakihana, Masahide Yamamoto, Mitsuko Iiyama, et al.
Internal Medicine (Tokyo, Japan)|May 7, 2016
Postoperative Atypical Hemolytic Uremic Syndrome Treated Successfully with EculizumabShunichiro Yasuda, Masahide Yamamoto, Tetsuya Fukuda, et al.
Cancer Genetics and Cytogenetics|February 22, 2005
Clonal evolution with inv(11)(p15q22) and NUP98/DDX10 fusion gene in imatinib-resistant chronic myelogenous leukemiaMasahide Yamamoto, Kazuhiko Kakihana, Tetsuya Kurosu, et al.
Biochemical and Biophysical Research Communications|June 15, 2004
The two major imatinib resistance mutations E255K and T315I enhance the activity of BCR/ABL fusion kinaseMasahide Yamamoto, Tetsuya Kurosu, Kazuhiko Kakihana, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|December 24, 2002
Endoscopic versus conventional open thyroid lobectomy for benign thyroid nodules: a prospective studyMasahide Yamamoto, Akira Sasaki, Hiroshi Asahi, et al.
Molecular and Clinical Oncology|March 24, 2015
Evaluation of the efficacy of maintenance therapy for low-to-intermediate-risk acute promyelocytic leukemia in molecular remission: A retrospective single-institution studyMasahide Yamamoto, Keigo Okada, Hiroki Akiyama, et al.
Anticancer Research|September 15, 2019
Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management StrategyMasahide Yamamoto, Keisuke Tanaka, Yoshihiro Umezawa, et al.
Cureus|October 18, 2024
Comparative Study of Metabolic Tumor Volume in Multiple Myeloma and Related Plasma Cell Dyscrasias: 11C-Acetate PET vs. 18F-FDG PETMomo Wakui, Junichi Tsuchiya, Chikara Kase, et al.
In Vivo (Athens, Greece)|September 1, 2019
Methotrexate-associated Classical Hodgkin Lymphoma Shows Distinct Clinicopathological Features but Comparable Clinical Outcomes With Sporadic CasesKota Yoshifuji, Yoshihiro Umezawa, Ayako Ichikawa, et al.
Pageof 8